MoneyWorks4Me

Alembic Pharmaceuticals gets EIR from USFDA for API - I, API - II facility at Panelav

15 Sep 2025 Evaluate

Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) for the inspection carried out by US Food and Drug Administration (USFDA) at the company's API - I & API - II facility located at Panelav. The inspection was conducted from May 26, 2025 to May 31, 2025.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..